The current stock price of MLSS is 0.304 USD. In the past month the price decreased by -25.6%. In the past year, price decreased by -60.72%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.67 | 222.97B | ||
| ISRG | INTUITIVE SURGICAL INC | 65.23 | 201.33B | ||
| BSX | BOSTON SCIENTIFIC CORP | 32.84 | 143.55B | ||
| SYK | STRYKER CORP | 27.96 | 140.79B | ||
| IDXX | IDEXX LABORATORIES INC | 57.57 | 58.07B | ||
| BDX | BECTON DICKINSON AND CO | 13.36 | 55.24B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.12 | 49.98B | ||
| RMD | RESMED INC | 25.33 | 36.59B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.66 | 34.90B | ||
| DXCM | DEXCOM INC | 32.38 | 23.62B | ||
| PODD | INSULET CORP | 72.47 | 23.31B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.39 | 18.26B |
Milestone Scientific, Inc. is a biomedical technology research and development company, which patents, designs, and develops diagnostic and therapeutic injection technologies and instruments. The company is headquartered in Livingston, New Jersey and currently employs 17 full-time employees. The firm patents, designs, develops and commercializes diagnostic and therapeutic injection technologies and devices for medical and dental use. The firm operates through two segments: dental and medical. The firm has developed a computer-controlled anesthetic delivery device, its DPS Dynamic Pressure Sensing Technology System, to meet the needs of various subcutaneous drug delivery injections and fluid aspiration. Its device, using The Wand, a single-use disposable handpiece, is marketed in dentistry under the trademarks CompuDent and STA Single Tooth Anesthesia System, and is suitable for all dental procedures that require local anesthetic. The dental devices are sold in the United States, Canada and in over 41 other countries. In addition, the Company has obtained CE mark approval for certain medical devices, which can be marketed and sold in various European countries.
MILESTONE SCIENTIFIC INC
220 S Orange Ave
Livingston NEW JERSEY 07068 US
CEO: Leonard Osser
Employees: 17
Phone: 19735352717
Milestone Scientific, Inc. is a biomedical technology research and development company, which patents, designs, and develops diagnostic and therapeutic injection technologies and instruments. The company is headquartered in Livingston, New Jersey and currently employs 17 full-time employees. The firm patents, designs, develops and commercializes diagnostic and therapeutic injection technologies and devices for medical and dental use. The firm operates through two segments: dental and medical. The firm has developed a computer-controlled anesthetic delivery device, its DPS Dynamic Pressure Sensing Technology System, to meet the needs of various subcutaneous drug delivery injections and fluid aspiration. Its device, using The Wand, a single-use disposable handpiece, is marketed in dentistry under the trademarks CompuDent and STA Single Tooth Anesthesia System, and is suitable for all dental procedures that require local anesthetic. The dental devices are sold in the United States, Canada and in over 41 other countries. In addition, the Company has obtained CE mark approval for certain medical devices, which can be marketed and sold in various European countries.
The current stock price of MLSS is 0.304 USD. The price decreased by -0.56% in the last trading session.
MLSS does not pay a dividend.
MLSS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
MLSS stock is listed on the NYSE Arca exchange.
MILESTONE SCIENTIFIC INC (MLSS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.08).
The outstanding short interest for MILESTONE SCIENTIFIC INC (MLSS) is 0.25% of its float.
ChartMill assigns a fundamental rating of 2 / 10 to MLSS. MLSS may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months MLSS reported a non-GAAP Earnings per Share(EPS) of -0.08. The EPS increased by 37.92% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -86.63% | ||
| ROE | -208.8% | ||
| Debt/Equity | 0.25 |
8 analysts have analysed MLSS and the average price target is 2.04 USD. This implies a price increase of 571.05% is expected in the next year compared to the current price of 0.304.
For the next year, analysts expect an EPS growth of 20.67% and a revenue growth 6.02% for MLSS